• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Revenue Cycle Startup Rivet Lands $8.25M to Expand Price Transparency Platform

Share:

March 16, 2020

Highlights on this story:
  • Revenue cycle management startup Rivet raises $8.25M Series A funding to expand its healthcare price transparency platform.
  • The price transparency platform enables providers to give patients upfront pricing with the ability to pay prior to care via text while at the same time helping providers navigate the complex process that grants “in-network” status with insurance companies.

Rivet, a Salt Lake City, UT-based modern healthcare revenue cycle management company delivering healthcare price transparency to patients, announced that it has raised $8.25 million in a Series A round of funding led by Menlo Ventures and return backers Lux Capital and Pelion Venture Partners.

Making Out of Pocket Estimates Easy for Providers & Patients

he RCM marketplace is a $30 billion market with 30–60% of revenue being lost in uncollected debt. Rivet’s goal is to simplify this space through its technology. Founded in 2018, Rivet’s intelligent tech platform is used by healthcare practices across the country to bring price transparency to patients.

Currently, patients discover the cost of care up to 60 days after their doctor visits via traditional mail. From there, patients often have to call or log in to an antiquated online portal to reconcile their bills. Rivet’s platform enables providers to give patients upfront pricing estimates with the ability to pay prior to or shortly after receiving care in a way that is convenient to them, even via email or text.

The platform also leverages machine learning to help providers navigate the complex process that grants “in-network” status with insurance companies. Rivet’s reimbursement contract management tool allows providers to easily track and audit their payer contracts while also benchmarking what competitive rates should be from plan to plan. Where understanding healthcare contracting and pricing used to need years of experience, Rivet’s platform makes it possible with a user-friendly interface and the click of a button.

Expansion Plans for Cost Transparency Platform

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Rivet will be using this round of funding to enhance its capabilities as a price transparency platform, grow its team and take the next steps to become an end-to-end patient billing suite that helps both patients and providers better manage healthcare costs.

“The current healthcare system is clearly not working for either the patient or the healthcare providers. This investment is proof that our investors are committed to fixing a broken system,” said Ted Ferrin, co-founder and CEO of Rivet. “This funding will help us continue building products that can be seamlessly integrated in the current system to empower both healthcare providers and patients by improving transparency.”

Source: Hit Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Lab Notebook learns to communicate with laboratory devices: labfolder acquires cubuslab and becomes LabforwardLab Notebook learns to communicate with laboratory devices: labfolder acquires cubuslab and becomes Labforward
  • WELL Health to Acquire Majority Stake in SleepWorks Medical Inc.WELL Health to Acquire Majority Stake in SleepWorks Medical Inc.
  • Moxe Health’s $25M Boost from Trinity Reshapes Data ExchangeMoxe Health’s $25M Boost from Trinity Reshapes Data Exchange
  • Walmart Brings One Drop’s Diabetes Management Platform to Hundreds of Retail Stores NationwideWalmart Brings One Drop’s Diabetes Management Platform to Hundreds of Retail Stores Nationwide
  • Invitae Reports Inducement Grants Under NYSE Rule 303A.08 to Former Employees of Singular Bio, Inc. in Connection with Closing of AcquisitionInvitae Reports Inducement Grants Under NYSE Rule 303A.08 to Former Employees of Singular Bio, Inc. in Connection with Closing of Acquisition
  • ANI Pharmaceuticals Announces Acquisition of Fluconazole TabletsANI Pharmaceuticals Announces Acquisition of Fluconazole Tablets
  • Hippocratic AI | Revolutionizing Healthcare with Generative AIHippocratic AI | Revolutionizing Healthcare with Generative AI
  • Serenity Bioworks Acquires DC-TAB for Lupus NephritisSerenity Bioworks Acquires DC-TAB for Lupus Nephritis

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications